Avita Business Summary

AViTA Corporation (4735.TWO) is a Taiwan-based medical technology firm specializing in the research, development, and manufacturing of home healthcare and point-of-care diagnostic devices. The company generates revenue primarily through the global distribution of its proprietary and OEM/ODM medical equipment, which is categorized into segments such as thermometry, hypertension management, and respiratory care. Its core product portfolio includes non-contact infrared thermometers, oscillometric blood pressure monitors, nasal aspirators, and pulse oximeters. To maintain its competitive edge and mitigate geopolitical trade risks, AViTA has recently expanded its manufacturing footprint with a new facility in Thailand, slated for mass production in Q2 2026. Within the medical device landscape, AViTA competes directly with major players such as Omron, Microlife, Rossmax, and Health & Life, positioning itself as a high-efficiency manufacturer with a strong emphasis on clinical validation and international regulatory compliance. Founded in 1996 and headquartered in New Taipei City, AViTA is led by a veteran executive team with deep roots in the Taiwanese medical electronics industry. Chairman Minghui Zhuang, who has presided over the board since 2003, oversees the company’s long-term strategic direction, while Qiang Ji serves as the General Manager and Vice Chairman, a role he assumed in 2024 to drive operational excellence. The technical leadership is anchored by Chief Technology Officer Yang-Xing Ou, who leads the firm’s R&D and product innovation initiatives, supported by Chief Financial Officer Zhong Jie Zhuang. The board of directors is composed of a mix of industry representatives and independent experts, including Boon Cheng Lim and Sheng Chang Zhan, ensuring robust corporate governance as the company scales its international presence.